Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 7, 1998, Pages 525-530

  Fallab Stubi, C L ^a   Zellweger, J P ^a   Sauty, A ^a   Uldry, Ch ^a   Iorillo, D ^a   Burnier, M ^a  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

Author keywords

Compliance; Electronic monitoring; Prevention; Tuberculosis

Indexed keywords

ISONIAZID;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DRUG URINE LEVEL; FEMALE; HUMAN; INFECTION CONTROL; MALE; MONITOR; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; DRUG PACKAGING; ELECTRONICS; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PATIENT COMPLIANCE; TUBERCULOSIS;

EID: 0031874324     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Combs D L, O'Brien R J, Geiter L J. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med 1990; 112: 397-406.
2. Snider D E, Caras G J, Koplan J P. Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA 1986; 255: 1579-1583.
3. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isomazid preventive therapy for tuberculosis: five years follow-up in the IUAT trial. Bull World Health Organ 1982; 60: 555-564.
4. Pape J W, Jean S S, Ho J L, Hafner A, Johnson Jr W D. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-272.
5. Geiseler P J, Nelson K E, Crispen R G. Tuberculosis in physicians. Compliance with preventive measures. Am Rev Respir Dis 1987; 135: 3-9.
6. Fox W. Compliance of patients and physicians: experience and lessons from tuberculosis - II. Brit Med J 1983; 287: 101-105.
7. Cuneo W D, Snider D E. Enhancing patient compliance with tuberculosis therapy. Clin Chest Med 1989; 10: 375-380.
8. Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tubercle Lung Dis 1993; 74: 32-37.
9. Pablos-Mendez A, Knirsch C A, Barr G, Lerner B H, Frieden T R. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med 1997; 102: 164-170.
10. Sanmarti L S, Megias J A, Gomez M N A, et al. Evaluation of the efficacy of health education on the compliance with antituberculosis chemoprophylaxis in school children. A randomized clinical trial. Tubercle Lung Dis 1993; 74: 28-31.
11. Jin B W, Kim S C, Mori T, Shimao T. The impact of intensified supervisory activities on tuberculosis treatment. Tubercle Lung Dis 1993; 74: 267-272.
12. Weis S E, Slocum P C, Blais F X, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1184.
13. Iseman M D, Cohn D L, Sbarbaro J A. Directly observed treatment of tuberculosis. We can't afford not to try it. N Engl J Med 1993; 328: 576-578.
14. McDonald R J, Memon A M, Reichman L B. Successful supervised ambulatory management of tuberculosis treatment failures. Ann Intern Med 1982; 96: 297-302.
15. Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992; 68(Suppl 3): S49-S59.
16. Averbuch M, Weintraubn M, Pollack D J. Compliance assessment in clinical trials: the MEMS device. J Clin Res Pharmacoepidemiol 1990; 4: 199-204.
17. Kruse W, Weber E. Dynamics of drug regimen compliance - its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990; 38: 561-565.
18. Korenblit P, Mascolo A, Perino S, Adler J, Seyburn D, Indik D. Outcome of tuberculosis worksite prevention program. Am Rev Respir Dis 1993; 147, Part 2: A722.
19. Racine-Perreaud E, Zellweger J P. Chimiothérapie antituberculeuse préventive chez 250 patients du dispensaire antituberculeux de Lausanne. Schweiz med Wschr 1994; 124: 705-711.
20. Moulding T, Onstad G D, Sbarbaro J A. Supervision of outpatient drug therapy with the medication monitor. Ann Intern Med 1970; 73: 559-564.
21. Cheung R, Dickins J, Nicholson P W, et al. Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device. Eur J Clin Pharmacol 1988; 35: 401-407.
22. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989; 46: 163-168.
23. Youngleson S M, Joubert G. A comparison of cross-sectional and longitudinal survey methods in measuring patient compliance with tuberculosis treatment. S Afr Med J 1991; 80: 331-335.
24. Taylor G H. The tuberculosis epidemic and the pharmacist's role. American Pharmacy 1992; vol NS32, No 7: 41-44.